Visual insufflation port

Information

  • Patent Grant
  • 11123105
  • Patent Number
    11,123,105
  • Date Filed
    Wednesday, November 21, 2018
    6 years ago
  • Date Issued
    Tuesday, September 21, 2021
    3 years ago
Abstract
A visual insufflation obturator is provided. The obturator includes seals, valves, screens and/or various other tip features to eliminate the ingress of fluids, matter and/or gas that can disrupt the visual field of the laparoscope disposed within the obturator. The obturator provides additional features such as lens and anti-fog features to further increase visibility of the scope, efficiently insufflate the patient and ultimately provide an access channel into the insufflated abdomen once the visual insufflation obturator is removed.
Description
BACKGROUND

The present invention generally relates to surgical access devices for entering a patient's body, and in particular to visual insufflation obturators providing a visual and gaseous pathway.


Laparoscopic surgery of the abdominal area typically requires the introduction of an insufflation gas into the peritoneal cavity of the patient. The insufflation gas is usually pressurized to about 10 mm Hg above atmospheric pressure. This in turn lifts the abdominal wall away from the organs underlying it. Cannulas having seals are then placed at various locations through the abdominal wall to allow the use of a laparoscope and operating instruments. It is well known that establishing access to a non-inflated peritoneal cavity can be a very dangerous part of any laparoscopic procedure. The most common method to achieve insufflation is to pass a sharp needle through the abdominal wall and into the abdominal region, and then inject a gas through the needle and into the region thereby creating an enlarged or ballooned cavity to accommodate a laparoscopic procedure. Unfortunately, insertion of the needle has been required without any visual aid to facilitate location of the sharp needlepoint.


In order to reduce the probability of inadvertent penetration of delicate internal organs in this “blind” procedure, the sharp insufflation needle has been provided with a blunt or rounded member disposed within the lumen of the needle, and biased by a spring to an extended position beyond the needle tip. A drawback of this “blind” insertion is the surgeon may inadvertently contact the organs and tissues underlying the abdominal wall such as major blood vessels and the intestinal tract. Once access is gained, it can take several minutes for the gas to insufflate the abdomen and while this is happening the surgeon may be unaware of any complications caused by the insertion of the needle.


The Hasson technique can also be used to gain initial access to the peritoneal cavity. This technique involves making a mini-laparotomy and using the fingers to bluntly dissect the tissues of the abdominal wall and thereby creating an access similar to an open surgical procedure. Although generally considered less complicated, it can result in an access site that is not well suited for the subsequent introduction and use of a laparoscopic cannula. The cannula is typically held in place with an additional device that allows the cannula to be tied down with sutures to prevent it from slipping out of the abdominal wall. This may also leave a large defect and is difficult to perform in large abdominal walls.


Some surgeons have used trocar cannulas with an obturator for the initial entry into the peritoneal cavity. However, in order to allow the subsequent introduction of insufflation gas through the cannula, the trocar cannula must be inserted all the way through the wall of the abdomen and this in turn can be potentially dangerous as the tip of the trocar may have to advance as much as one inch beyond the distal surface of the abdominal wall and into the underlying anatomical structures. Additionally, the obturator must thereafter be removed in order to allow the introduction of the insufflation gas. As such, there remains a need in the art for an improved surgical instrument that provides enhanced visual entry and visual insufflation that minimizes the risks to organs, tissues and vessels underlying a body wall.


SUMMARY

A visual insufflation obturator/port is provided. In one aspect, a visual insufflation obturator comprises an elongate body having a proximal end, a distal end and a body lumen extending from the proximal end of the elongate body to the distal end of the elongate body. A handle is connected to the proximal end of the elongate body and has a handle lumen extending from a proximal end of the handle to the proximal end of the elongate body and is connected to the body lumen. A transparent tip is connected to the distal end of the elongate body and has a tip cavity. The tip has an outer surface with an aperture extending through the outer surface into the tip cavity and defines an insufflation gas pathway from the elongate body out through the aperture. A micro-seal is located within the tip cavity and is adjacent to the aperture.


In one aspect, a visual insufflation obturator comprises an elongate body having a proximal end, a distal end and a body lumen extending from the proximal end of the elongate body to the distal end of the elongate body along a longitudinal axis of the elongate body. A handle is connected to the proximal end of the elongate body. A transparent bladeless tip without cutting edges is connected to the distal end of the elongate body. The tip has a tip cavity and an outer surface with an aperture extending through the outer surface into the tip cavity and a micro-seal is located within the aperture of the tip between the outer surface and the tip cavity.


A visual insufflation obturator in one aspect comprises an elongate body having a proximal end, a distal end and a body lumen extending from the proximal end of the elongate body to the distal end of the elongate body. A handle is connected to the proximal end of the elongate body and has a handle lumen extending from a proximal end of the handle to the proximal end of the elongate body and is aligned to the body lumen. A transparent tip is connected to the distal end of the elongate body and has a tip cavity aligned to the handle lumen. The tip has a distal enclosed end and an outer surface extending from the distal end of the elongate body to the distal enclosed end with an aperture extending through the outer surface into the tip cavity. A laparoscope seal attached to the proximal end of the elongate body comprises an anti-fog applicator saturated with an anti-fog solution and positioned in a direct pathway through the seal and into the elongate body, the laparoscope seal having a zero seal and an instrument seal axially aligned to and preceding the zero seal.


In one aspect, a visual insufflation obturator comprises an elongate body having a proximal end, a distal end and a body lumen extending from the proximal end of the elongate body to the distal end of the elongate body. A handle is connected to the proximal end of the elongate body and has a handle lumen extending from a proximal end of the handle to the proximal end of the elongate body axially aligned to the body lumen. A transparent tip is connected to the distal end of the elongate body and has a tip cavity. The tip has an outer surface with an aperture extending through the outer surface into the tip cavity and a lens is located within the tip cavity before the aperture and a distal enclosed end of the transparent tip, the lens being coated with an anti-fog solution.


In one aspect, a visual insufflation obturator comprises an elongate body having a proximal end, a distal end and a body lumen extending from the proximal end of the elongate body to the distal end of the elongate body. At least one insufflation channel extends parallel to the body lumen starting from a body aperture positioned perpendicular to a longitudinal axis of the elongate body and through the elongate body to the body lumen defining an inflow insufflation gas pathway from outside the elongate body into the body lumen. A handle is connected to the proximal end of the elongate body and having a handle lumen extending from a proximal end of the handle to the proximal end of the elongate body axially aligned to the body lumen. A transparent bladeless non-cutting tip is connected to the distal end of the elongate body and has a tip cavity axially aligned to the handle lumen, the tip having a distal enclosed end and an outer surface extending from the distal end of the elongate body to the distal enclosed end with a tip aperture extending through the outer surface into the tip cavity and defining an outflow insufflation gas pathway from the at least one insufflation channel out through the tip aperture. Means for allowing antegrade insufflation gas flow out of the aperture and preventing retrograde insufflation gas flow into the elongate body, e.g., a micro-seal, is located within the tip cavity.


Many of the attendant features of the present invention will be more readily appreciated as the same becomes better understood by reference to the foregoing and following description and considered in connection with the accompanying drawings in which like reference symbols designate like parts throughout.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a side view of a visual insufflation port in accordance with various aspects of the present invention;



FIGS. 2-3 are side views of an obturator in accordance with various aspects of the present invention;



FIG. 4 is a cross-sectional view of an obturator in accordance with various aspects of the present invention;



FIG. 5 is a cross-sectional view of a tip of an obturator in accordance with various aspects of the present invention;



FIG. 6 is a cross-sectional view of a laparoscopic seal and a proximal end of an obturator in accordance with various aspects of the present invention;



FIGS. 7-14 are side views of various tips of an obturator in accordance with various aspects of the present invention;



FIGS. 15-27 are cross-sectional views of various tips of an obturator in accordance with various aspects of the present invention;



FIG. 28 is a side view of a tip of an obturator in accordance with various aspects of the present invention;



FIGS. 29-33 are cross-sectional views of various tips of an obturator in accordance with various aspects of the present invention;



FIG. 34 is a cross-sectional view of an obturator in accordance with various aspects of the present invention; and



FIGS. 35-37 are cross-sectional views of various tips of an obturator in accordance with various aspects of the present invention.





DETAILED DESCRIPTION OF THE INVENTION

Aspects of an obturator with visualization and insufflation properties are provided. In one aspect, a micro-seal within the distal tip of the obturator enables the outflow (antegrade) of insufflating gasses such as carbon dioxide yet prevents the inflow (retrograde) of moisture and/or body fluids which could obstruct or impair the visualization properties through the distal tip of the obturator. The distal end of the obturator or portions thereof is formed of a material to enable visualization of tissue during the insertion of the obturator through a body wall. The obturator enables the insertion of a laparoscope 40, which typically includes an imaging element and fiber optic light fibers.


During an operational exemplary use, the obturator is inserted into and through trocar seal housing 30 and cannula 20. A laparoscope 40 is inserted into the proximal end of the obturator and advanced to the distal tip of the obturator. An endoscopic video camera is attached to the proximal end of the laparoscope. As the surgeon advances the trocar through the body wall, the surgeon can visually observe the tissue through the obturator tip as the tissue is being separated without cutting via a video monitor, which is connected to the endoscopic video camera. The surgeon can also readily determine when the body wall has been traversed to enable the most distal portion of the obturator to enter the body cavity. The most distal portion of the obturator includes insufflation vent holes or apertures through which an insufflation gas may flow from the obturator and into the peritoneal cavity. Insufflation of the abdominal cavity can then occur with minimal entry into the cavity by the obturator thereby reducing unintended contact with tissue or organs. The insufflated abdominal cavity enlarges the surgical area further reducing unintended contact and complications. The obturator can then be removed from the trocar cannula leaving behind a readily usable access port into the abdominal cavity.


A micro-seal is positioned just proximal to the insufflation apertures or vent holes on the obturator. The micro-seal is located inside the distal tip of the obturator and prevents the ingress of moisture and body fluids, which could impair or obstruct the visibility through the tip of the obturator. The micro-seal acting as a zero seal allows the flow of insufflation gas through the obturator and out through the insufflation vent holes.


In one aspect, the bladeless (non-cutting) obturator provides visualization of body tissue fibers as they are being separated, a controlled traversal across a body wall, and a trocar, which enables insufflation of a body cavity through the distal tip of the obturator. The obturator accommodates a laparoscope without imposing special requirement on the laparoscope used with the obturator. The bladeless obturator tip also extends beyond the distal end of the trocar cannula and thereby advances ahead of the trocar cannula that can have tips that are angled or shaped with a point or sharp tip. Thus, advancement of the trocar cannula and obturator can be accomplished while avoiding unintended contact by the trocar cannula.


As shown in FIGS. 1-6, a visual insufflation obturator is shown having an elongate body 5 extending from an obturator handle 3 to a distal tip 7. A laparoscope seal 9 is attached to the obturator handle 3. The elongate body or shaft 5 is hollow having a body lumen extending from the proximal end of the body to a distal end and continuing into a cavity formed in the tip 7. The tip is bladeless with non-cutting edges or surfaces. The handle 3 is hollow having a handle lumen extending from its proximal end to its distal end in communication with the body lumen of the elongate body 7. As such, a viewing channel or pathway is provided from the proximal end of the obturator handle 3 through the elongate body 5 to the tip 7. Also, a gaseous channel or pathway is provided from the elongate body 5 to the tip 7.


The tip 7 has one or more apertures or holes disposed through the tip. The aperture provides a gaseous pathway from the lumen (interior) of the elongate body and out through the aperture in the tip 7 (exterior of the obturator). In one aspect, one or more apertures or holes through the elongate body provides a gaseous pathway for the flow of insufflation gas from a trocar cannula into the elongate body and out through the aperture in the tip 7, the tip extending beyond the distal end of the trocar cannula. The elongate body, in one aspect, can have one or more insufflation channels embedded in or attached to the walls of the elongate body in gaseous communication with the aperture(s) in the tip. Pressurized insufflation gas in one aspect is introduced through the stopcock 2 into the trocar cannula 20. Trocar seal housing 30 prevents the gas from escaping proximally out from the cannula 20. The gas from the trocar cannula 20 enters the one or more apertures or holes in the elongate body and flows out distally through the aperture in the tip.


The tip 7, in one aspect, has a micro-seal 11 positioned therein through which insufflation gasses may flow and then out through the hole or aperture 12 in the tip. However, the micro-seal acting as a zero seal is normally closed and therefore prevents moisture and body fluids from flowing into the tip of obturator. In the absence of the micro-seal, moisture and body fluids could flow into the tip 7 of the obturator and create condensation on the inner walls or lumen of the obturator (e.g., elongate body and/or tip) and on the lens of the laparoscope. The condensation can diminish the visibility through the obturator and in some cases, can entirely obstruct the view through the tip 7 of the obturator. The micro-seal 11 prevents the ingress of moisture and body fluids and therefore enhances the visibility through the tip of the obturator while also enabling the flow of insufflation gasses through the tip of the obturator. The micro-seal size is substantially diminished in size and thereby reduces obstruction of the view of a laparoscope inserted into the obturator. In one aspect, the micro-seal is about 2 to 4 mm in diameter and about 2 to 3 mm tall. The micro-seal provides a one-way pathway allowing insufflation gas to flow out through the tip while preventing gas, fluid, etc. from entering back through the micro-seal.


The obturator handle 3 provides a place for a surgeon to hold or grasp the obturator. The obturator handle 3 as shown has a generally domed shape that is connectable to a trocar seal housing 30. In one aspect, the handle is a pistol-like grip or generally flanged portion providing finger grips. The obturator handle, in one aspect, can also be manipulated to apply torque to the obturator for insertion of the obturator into the body cavity.


In one aspect, a laparoscope seal 9 is positioned at the proximal end of the obturator handle 3. The laparoscope seal 9 has a zero seal 8 preventing the egress of insufflation gases when the obturator is used without an inserted laparoscope. The laparoscope seal 9 also includes a septum seal 10 forming a seal with a laparoscope to prevent the egress of insufflation gases when the obturator is used with an inserted laparoscope. The zero seal 8 in one aspect is a double duckbill valve that minimizes the forces utilized to insert and remove the laparoscope. By minimizing the forces to insert and remove the laparoscope from the laparoscope seal 9, the application of lubricants such as silicone grease or silicone fluid on the laparoscope seal is obviated or minimized. Some form of lubrication such as silicone grease or silicone fluid can be used to reduce the insertion and removal forces of laparoscopic instrumentation. These lubricants however can be transferred to the lens of a laparoscope as the laparoscope is inserted through the trocar seal resulting in distorted and diminished visibility through the laparoscope. As such, the laparoscope seal 9 in one aspect enables the laparoscope to be inserted into the obturator and withdrawn from the obturator with minimal force while ensuring that optimal visibility through the laparoscope is maintained.


The laparoscope seal 9 also minimizes the torque required to rotate the obturator relative to the inserted laparoscope. The trocar cannula with the optical obturator is rotated in an alternating clockwise and counterclockwise fashion during traversal across a body wall. During this time, it is desirable to keep the laparoscope in a rotationally fixed position relative to the trocar and the optical obturator to ensure a stable image on the video monitor. The double duckbill valve incorporated into the laparoscope seal enables the obturator to be easily rotated relative to the inserted laparoscope.


In one aspect, the micro-seal 11 that prevents the ingress of moisture is located entirely within the inner walls of the tip 7 of the obturator. With the micro-seal being an internal component, it is not possible to dislodge or separate the micro-seal from the obturator and thereby fall into the surgical site. The micro-seal 11 in one aspect is a double duckbill configuration, which enables the maximum flow rate through the valve while minimizing the overall size of the duckbill valve. The double duckbill valve also reduces the amount of pressure required to open the duckbill valve during initial flow of insufflation gasses. This can be desirable as some pressures used during the insufflation of a body cavity are low, e.g., about 15 mm Hg.


The duckbill or double duckbill valve 11 in one aspect is a single-piece component, which is injection molded of a transparent material such as silicone or Kraton® to ensure that visibility through the duckbill valve is achieved and thereby ensuring a further reduction in potential obstruction of a laparoscope's view. The duckbill valve 11 in one aspect is molded from an opaque material such as polyisoprene to provide contrast between the duckbill valve and the obturator. The duckbill valve 11 in one aspect is tinted or colored to provide contrast and to visually indicate proper positioning of the distal tip of the obturator relative to a body wall.


The duckbill valve 11 is fixed in position via an interference slip fit within the obturator. The obturator in one aspect has a small cylinder or cylindrical spacing formed or carved within the tip of the obturator that is in fluid communication with the insufflation vent holes. The duckbill valve 11 is inserted into the cylinder, e.g., via a mandrel and remains in place via the interference slip fit and thereby avoids the use of adhesives or other attachments that may obstruct a laparoscope's view. In one aspect, a flange, lip or projection portion of the micro-seal is wedged into the cylindrical space in which a ledge engaged with the flange secures the micro-seal in place.


The obturator in traversing the body wall or conduit can encounter fluids, such as gastric fluids that may damage a laparoscope, and tissue, e.g., fat that may obscure the laparoscope's view. The micro-seal prevents such fluids and tissue from contacting the laparoscope (often an expensive and delicate instrument). The introduction of insufflation gas via the insufflation gas pathway through the micro-seal and out of the tip aperture can also clear the view by expelling fluid or tissue that entered inside and/or positioned around the tip. The obturator also allows subsequent use of the obturator in the same surgical procedure, for example, use for a second, third or more insertion sites as used in some laparoscopic procedures. The micro-seal acting as a zero seal prevents the egress or escape of gas from the insufflated cavity or conduit. As such, the obturator could be used to form additional insertion sites into the insufflated cavity without losing pneumoperitoneum. The subsequent use of the obturator reduces surgical cost, time and other issues that arise from instrument exchanges or introducing additional instruments to the surgical procedure. The micro-seal can also obviate the use of other seals with the initial and/or subsequent use of the obturator.


In one aspect, the obturator shaft 5 is configured with integral sealing bands 15 at either distal or proximal ends or both to affect a seal between the obturator 10 and mating components of a trocar or other portions of the obturator to prevent the egress of insufflation gases. The obturator 10 in one aspect has a small integral band of material 15 at its distal tip designed to create an interference fit between the obturator 10 and the trocar cannula 20 with the obturator inserted into the trocar cannula. The interference fit prevents the outflow of insufflation gas between the outer wall of the obturator and the inner bore of the cannula 20. The obturator in one aspect has a small integral band of material 16 at its proximal end arranged to create an interference fit between the outer wall of the obturator 10 and the inner wall of the trocar handle/seal housing 30. The interference fit prevents the outflow of insufflation gas between the inner bore of the trocar handle 30 and the outer wall of the obturator 10.


In one aspect, the laparoscope seal 9 prevents the egress of insufflation gas and is positioned on the proximal end of the obturator handle 3 via a snap fit with the handle. The laparoscope seal comprises a proximal septum seal 6 and a distal double duckbill valve 8. The laparoscope seal in one aspect is a single-piece component, which is injection molded of a transparent or opaque elastomeric material such as silicone, polyisoprene, or Kraton. The laparoscope seal 9 in one aspect is coated with a dry lubricant or treated with various materials to further reduce the forces used to insert and withdraw a laparoscope 40 and/or reduce the friction associated with insertion and withdrawal of the laparoscope. Examples of such coatings and treatments include Teflon® coatings, parylene coatings, plasma surface treatments, and chlorination treatments. In one aspect, the duckbill valve of the laparoscope seal 9 is a single duckbill valve.


As shown in FIGS. 7-11, the tip 7 of the obturator can have varied configurations each providing a particular functionality and characteristics utilized in a particular surgical procedure and/or user. For example, the obturator has a sharp pointed tip 16 (FIG. 7), a pyramidal tip 17 (FIG. 8), a bladed tip 18 (FIG. 9), sharp edges 18a, or sharpened edges to facilitate traversal through body tissue. The obturator in one aspect has a conical blunt tip 19 configuration to facilitate traversal through body tissue (FIG. 10). The obturator has a radiused blunt tip 20 for traversal through an existing body orifice or through relatively soft or fatty tissue (FIG. 11). In one aspect, the tip is bladeless with no cutting or sharp edges or surfaces. The bladeless tip in one aspect has a generally tapered configuration with an outer surface extending distally to a blunt point with a pair of side sections having a common shape and being separated by at least one intermediate section. The side sections extend from the blunt point radially outwardly with progressive positions proximally along the axis. With this aspect, the tapered configuration facilitates separation or spreading of different layers of the body tissue and provides proper alignment of the tip between the layers. The distal portion of the side sections are twisted radially with respect to the proximal portion of the side sections. The distal portion of the intermediate section is twisted in a first radial direction and the proximal portion of the intermediate section is twisted in a second radial direction opposite the first radial direction. Each tip has an insufflation vent hole or aperture 12 and a micro-seal placed within the tip adjacent to the vent hole 12. The tip 7 and/or shaft 5 or portions thereof in one aspect can formed of a rigid material, flexible material or a combination thereof.


In one aspect, the tip provides and allows viewing through the tip or portion thereof, for example, by using a laparoscope inserted into the obturator. The tip or portions thereof is transparent. One would recognize that transparent would include translucent and other means that provides/allows viewing through at least a portion of the tip with a laparoscope. Windows, viewing channels or magnifiers could be also added or embedded into the tip to enhance laparoscope vision. The tip in one aspect may have one or more indicators, markings or deformations on the tip for example to identify the position of the tip. Such indicators may have to be positioned close to the aperture to prevent interference with the viewing path of the laparoscope. Likewise, the aperture and/or micro-seal are positioned close to the most distal portion of the tip to also prevent interference with the viewing path of the laparoscope. For example, the aperture may be a few millimeters from the distal portion of the tip and a micro-seal a few millimeters away from the aperture.


Referring now to FIGS. 12-13, the obturator, in one aspect, has screens 21 across the insufflation apertures or vent holes 12 to prevent the ingress of body tissue such as fat into the insufflation vent holes and into tip 7 of the obturator. In place or in addition to the screens, the insufflation vent holes are configured with raised ribs 22 across the diameter of the holes to deflect body tissue away from the holes and thereby prevent the ingress of body tissue into the vent holes and into the tip of the obturator. As shown in FIG. 14, the obturator could also include integral tissue deflectors 23 just distal to the insufflation vent holes that would serve to move body tissue away from the holes and thereby prevent the ingress of body tissue into the holes and into the tip of the obturator. In one aspect, the tissue deflectors 23 are attached to the tip 7 and are made of an elastomeric material, such as rubber.


In one aspect, the internal micro-seal 11 is coated or treated with various materials to enable the duckbill valve to be slightly opened with less force and to increase the insufflation fluid flow characteristics of the duckbill valve. Examples of such coatings and treatments are Teflon® coatings, parylene coatings, plasma surface treatments, and chlorination treatments.


The internal micro-seal prevents the ingress of moisture and body fluids into the distal tip of the obturator. As previous described and also shown in FIGS. 15-16, the internal micro-seal of the obturator can have varied configurations each providing a particular functionality and characteristics utilized in a particular surgical procedure and/or user. For example, the internal micro-seal is a single or double duckbill valve, a flat disc type valve 25 with either a single slit or a plurality of slits, a double duckbill valve 26 with slits 27 running parallel to the distal end surface of the duckbill and to the longitudinal axis of the duckbill or a combination of valves thereof. In one aspect, the double duckbill valve with slits running parallel to the distal end surface of the duckbill and to the longitudinal axis of the duckbill are lengthen to run up the sides of the duckbill valve, thereby increasing the flow rate through the duckbill valve. In one aspect, the double duckbill valve has a single slit, which runs parallel to the distal end surface of the duckbill and to the longitudinal axis of the duckbill.


As previously described, the obturator is configured with the internal micro-seal and an insufflation vent hole at the most distal portion of the obturator tip next to the internal micro-seal. As shown in FIG. 17, the vent hole 12′ in one aspect is generally coaxial with the longitudinal axis of the obturator. The micro-seal 11 would normally be closed to prevent the ingress of moisture and body fluids. Under pressure from the insufflation gas, the micro-seal 11 would open to enable the flow of the insufflation gas into the body cavity.


Various other exemplary micro-seals will now be described. In FIG. 19, the obturator includes an external spring biased tip 35 at its distal end adjacent to the vent hole 12. The spring 33 biases the tip in a distal position. During traversal across a body wall, the body wall provides a compressive force on the spring tip 35 moving it to a proximal or sealed position. While in the proximal position, the spring tip 35 prevents the ingress of moisture and body fluids into the obturator by sealing the insufflation vent hole 12. Once the tip of the obturator enters the body cavity, the spring tip 35 deploys into the distal unsealed position. The insufflation gas is then transferred through perpendicular vent holes 12 and into the body cavity. The spring tip 35 in one aspect through movement between the sealed and unsealed positions and vice versa or color coding the tip, the spring tip 35 provides a visual indication to the surgeon that access into the body cavity had been achieved. The spring tip 35 in one aspect can provide an audible indication, e.g., a snap, to the surgeon that access into the body cavity had been achieved.


Referring now to FIGS. 20-21, in one aspect, the obturator has a non-biased moveable tip 36 at its distal end. The tip 36 is initially positioned in a distal unsealed position. During traversal across a body wall, the body wall provides a compressive force on the tip moving it to a proximal sealed position covering and sealing the vent hole 12. While in the proximal position, the tip 36 prevents the ingress of moisture and body fluids into the obturator. Once the tip of the obturator enters the body cavity, the movable tip would remain in the proximal sealed position. During pressurization of the obturator via insufflation gas, the moveable tip 36 would be forced to the distal unsealed position thus allowing the flow of insufflation gas through the vent hole 12 and into the body cavity. The movable tip in one aspect also comprises an o-ring or an elastomeric seal at its proximal end to assist in sealing the movable tip 36 with the internal walls of the obturator.


In FIGS. 22-23, the obturator in one aspect has an internal check valve in the distal tip of the obturator near the vent hole 12. The check valve comprises a piston 37 in a cylinder with a spring 38 positioned below the piston such that the piston is biased in a proximal sealed positioned. In the proximal sealed position, the piston seals one or more perpendicular insufflation vent holes 12. During pressurization of the obturator via insufflation gas, the top of the piston is exposed to the pressure and thus is moved to a distal unsealed position allowing the insufflation gas to flow through the vent holes 12 and into the body cavity. The piston 37 in one aspect is injection molded of a transparent polycarbonate material.


In FIG. 24, the obturator in one aspect has a membrane 41 positioned inside the distal tip 7 of the obturator which prevents the ingress of moisture and body fluids from the vent hole 12 yet allows insufflation gasses to flow through the membrane 41 and out the vent hole 12. The membrane 41 is porous and is formed from a hydrophobic material such as Gore-Tex® material. The membrane 41 is inserted into a small cylinder within the distal tip of the obturator adjacent to the insufflation vent hole 12. The membrane in one aspect is also bonded or welded to the inside wall of the distal tip 7 of the obturator.


Referring now to FIG. 25, in one aspect, the obturator has a perforated membrane 43 positioned inside the distal tip 7 of the obturator, as an alternative to a duckbill valve, for example, which prevents the ingress of moisture and body fluids from the vent hole 12. The perforated membrane 43 tears open or bursts apart when exposed to the pressure of the insufflation gas allowing the insufflation gas to flow out through the insufflation vent holes 12 and into the body cavity. The membrane 43 is formed from paper, cellophane, polyethylene, or polyurethane. The membrane 43 provides a single use visual insufflation port. For example, once the membrane 43 tears open and the insufflation gas flow halts, the ingress of moisture and/or body fluids will not be stopped by the torn perforated membrane 43. Thus, the re-use of the obturator is prevented thereby if so arranged the obturator can be designated as a disposable or single-use instrument preventing unintended operation or improper sterilization of the used obturator.


As shown in FIG. 26, the obturator in one aspect has an elastomeric external valve 45 such as an umbrella valve at the distal end of the obturator. The umbrella valve 45 is flush with the distal end of the obturator and covers longitudinal insufflation vent holes 12″. The umbrella valve moves distally relative to the tip 7 of the obturator when exposed to the pressure of the insufflation gas. The insufflation gas flows though the vent holes into the body cavity. The umbrella valve 45 is attached to the distal tip of the obturator via an integral elastomeric stem 46, which runs through a central axial hole in the obturator. As the obturator is pressurized via the insufflation gas, the elastomeric stem 46 elongates to enable the external portion of the umbrella valve 45 to move distally thus unblocking the vent holes 12″ and allowing insufflation gas to flow through the vent holes and into the body cavity. The umbrella valve 45 in its initial or normal condition also prevents the ingress of moisture and body fluids into the obturator during insertion into a body cavity by blocking the vent holes 12″ and ensures that optimal visibility through the laparoscope and the obturator is maintained. The umbrella valve 45 in one aspect is a single-piece component, which is injection molded of a transparent or opaque silicone, polyisoprene, or Kraton® material.


In FIG. 27, in one aspect, the obturator has an elastomeric internal umbrella valve 49 at the distal end of the obturator. The umbrella valve 49 is positioned just proximal to perpendicular or longitudinal vent hole 12′ at the distal tip of the obturator. The umbrella valve 49 covers one or more intermediate flow channels 42 to prevent the ingress of moisture and body fluids into the obturator during insertion into a body cavity. During pressurization from the insufflation gas, the elastomeric stem 48 of the umbrella valve 49 elongates to enable distal movement of the umbrella valve thus allowing the insufflation gas to flow through the intermediate flow channel or channels 42, out through the insufflation vent hole 12′, and into the body cavity. The internal umbrella valve 49 in one aspect is a single-piece injection molded component formed from a transparent or opaque silicone, polyisoprene, or Kraton® material.


In FIG. 28, the obturator in one aspect comprises one or more over-molded elastomeric valves 51 at the tip 17 of the obturator. The elastomeric valves 51 in one aspect are flat disc type valves that are formed of materials such as polyisoprene, Kraton®, and silicone materials. The elastomeric valves 51 encases perpendicular insufflation vent holes 12 at the distal tip 7 of the obturator and with slits 52 in the valves, such that the slits are normally closed to prevent the ingress of body fluids and moisture. Under pressure from the insufflation gas, the slits 52 in the valves slightly open enabling the insufflation gas to flow into the body cavity. Once pressure from the insufflation gas is removed, the slits 52 in the valves close thereby preventing the ingress of body fluids and moisture through the vent holes 12.


As shown in FIG. 29, in one aspect the obturator has a single over-molded elastomeric valve 53 covering a portion or apex portion of the distal tip 7. The elastomeric valve 53 encases a single longitudinal insufflation vent hole 12′ at the distal tip 7 of the obturator. The elastomeric valve 53 has a slit 54 at its distal end or apex generally aligned with the longitudinal vent hole 12′ such that the slit 54 is normally closed to prevent the ingress of body fluids and moisture. Under pressure from the insufflation gas, the slit 54 in the valve slightly opens enabling the insufflation gas to flow into the body cavity. The elastomeric valve 53 in one aspect also encases a pair of perpendicular insufflation vent holes. The elastomeric valve in one aspect encases a plurality of longitudinal insufflation vent holes 12′ at the distal end of the tip 7 of the obturator.


Referring now to FIG. 30, in one aspect, the obturator has an internal elastomeric flapper valve 55 located proximal to the perpendicular insufflation vent holes 12. The flapper valve 55 in one aspect is a single-piece component with a hinged flapper door. The flapper door remains closed during traversal of the obturator across a body wall to prevent the ingress of moisture and body fluids into the distal tip of the obturator from the vent holes 12. Under pressure from the insufflation gas, the flapper door opens enabling the insufflation gas to flow into the body cavity.


As shown in FIGS. 31-32, the obturator in one aspect has longitudinal and/or concentric inner and outer tubes 56, 57 where the inner tube 56 rotates freely within the outer tube 57 about a central axis of the obturator. Both the inner tube 56 and the outer tube 57 have insufflation vent holes 58, 59. During traversal across a body wall, the inner tube 56 is rotationally positioned such that the vent holes 58 in the inner tube 56 are not aligned with the vent holes 59 in the outer tube 57 thus creating a sealed condition to prevent the ingress of moisture and body fluids into the tip 7 of the obturator. Upon entry into the body cavity, the inner tube 56 is rotated such that the vent holes 58 on the inner tube are aligned with the vent holes 59 on the outer tube 57 allowing the flow of insufflation gas through the vent holes 58, 59 and into the body cavity. The inner tube 56 and/or the outer tube 57 in one aspect are injection molded of transparent polycarbonate materials.


Referring now to FIG. 33, the obturator shaft 5 is formed of a flexible material with a rigid or semi-rigid tip 7, arranged in one aspect to be used with a flexible scope, and without a cannula 20 to visually gain access to an area within a body including but not limited to a body conduit, a body cavity, a body organ, and a body wall. The obturator in one aspect has a longitudinal vent hole 12′ in the tip 7 with the micro-seal, e.g., duckbill valve, positioned proximal to the vent hole in the tip of the obturator. The micro-seal prevents the ingress of moisture, body tissue, and body fluids enabling precise visual placement of the tip 7 of the obturator into a targeted area. Once the obturator is properly positioned within the body, the area surrounding the obturator is insufflated with an insufflation gas to facilitate access to the targeted area. Another device can be inserted into a working channel of the obturator to conduct a surgical procedure such as brachytherapy or a breast biopsy. The surgical procedure, such as a breast biopsy, could be completed with or without visualization. The obturator could also include other types of internal micro-seals such as flapper valves or disc type valves. The internal micro-seal acting as a zero seal could also include a septum or instrument seal to seal around inserted instruments.


In one aspect, as the obturator traverses body tissue, pressurized insufflation gas are utilized to separate or dissect tissue away from the tip 7 of the obturator 5 thus lowering the force required to traverse the body tissue. The insufflation gas flows through the distal insufflation vent holes in the obturator 5 and into the body tissue forcing the body tissue away from the obturator tip 7. The insufflation gas is also used to separate relatively soft body tissue to enable access to a targeted body area within a relatively confined space. The obturator 5 in one aspect is formed of either a flexible material or a rigid material and used with or without a cannula 20.


In especially tortuous body conduits or surgical access pathways, the micro-seal preventing the ingress of fluid and/or tissue, e.g., fat, provides the ability to leave the laparoscope inserted into the obturator as it travels the pathway, thereby enhancing accuracy in movement of the obturator and access to the surgical site. As such, removal of the laparoscope to clean and/or de-fog the scope is avoided. Also, it may not be feasible, to subsequently re-enter the laparoscope and obturator into the body conduit after removal of the laparoscope.


As shown in FIG. 34, the inside wall 71 of the tip 7 of the obturator in one aspect is coated with an anti-fog solution to prevent excessive moisture from collecting on the inner wall of the obturator and to assist in maintaining optimal visibility through the tip of the obturator. The anti-fog solution is used with or without a valve in the tip of the obturator. In one aspect, a valve in the tip of the obturator is replaced with two perpendicular vent holes 12 in the tip 7 of the obturator. The anti-fog solution is applied via a dipping or coating process and then allowed to dry. Upon exposure to moisture, the anti-fog agent activates thereby preventing condensation from collecting on the inside walls 71 of the obturator. The anti-fog solution in one aspect is formulated from a mixture of 1% by weight docusate sodium and 99% by weight distilled water.


The laparoscope seal 9 in one aspect is coated with an anti-fog solution such that as the laparoscope passes through the laparoscope seal, the lens of the laparoscope is coated with the anti-fog solution. Once the laparoscope lens is coated with the anti-fog solution, condensation will not form on the laparoscope lens or is greatly minimized thereby maintaining optimal visibility during traversal of the obturator across a body wall. In one aspect, the laparoscope seal comprises an insert, pad or cap 73 saturated with an anti-fog solution. The insert 73 of the laparoscope seal 9 in one aspect is a form with a single slit, a plurality of slits, an aperture, or a combination thereof defining a passageway for the laparoscope through the foam. As the laparoscope is inserted into the obturator, the laparoscope passes through the saturated foam 73 thereby coating the lens of the laparoscope with the anti-fog solution. Once the lens of the laparoscope is coated with the anti-fog solution, condensation will not form on the laparoscope lens or is greatly minimized thereby maintaining optimal visibility during traversal of the obturator across a body wall. In one aspect, one or more applicators, e.g., foam or gel rollers or cylinders, saturated with anti-fog solution, is positioned within the handle of the obturator, such that as the laparoscope passes through the applicator coats the lens of the laparoscope with anti-fog solution.


The insert, pad or cap 73 in one aspect is formed, entirely or partially, from various materials such as silicone foam, polyurethane foam, polyethylene foam, ethylene vinyl acetate foam, PVC foam, felt, and cotton. The saturated cap in one aspect is bonded to the proximal end of the obturator and/or the proximal end of the laparoscope seal. To prevent evaporation of the anti-fog solution, the obturator in one aspect is packaged in a non-breathable package such as a mylar pouch or a foil pouch, both of which could be sterilized via gamma radiation sterilization or electron beam sterilization. The cap 73 in one aspect can also be contained within a sealed section of the obturator to prevent migration of the anti-fog solution from the cap.


In FIG. 35, the obturator in one aspect has a transparent lens 81 fitted adjacent to or into the tip 7 of the obturator that includes an internal elastomeric seal 83 configured to seal around the outside diameter of the laparoscope. The lens 81 encases the tip of the laparoscope to prevent fogging of the laparoscope. The lens 81 and/or the elastomeric seal 83 in one aspect is arranged to have a relatively close fit with the outside diameter of the laparoscope 40 to minimize the flow of moisture into the space between the lens 81 and the distal tip of the laparoscope. The lens in one aspect is also coated with an anti-fog solution to prevent condensation from collecting on the lens. The lens 81 in one aspect is shaped to provide additional magnification of the image. The additional magnification of the image provided by the lens enhances the visibility of the surrounding tissue during traversal of the obturator 10 across a body wall. The thickness of the lens 81 in one aspect ranges from about 0.001″ to about 0.250″. The lens 81 in one aspect is formed from various transparent materials including glass, infrared absorbent glass, polycarbonate, acrylic, polyvinyl chloride, PET, PETE, PETG, cellophane, silicone, polyurethane, polyetherimide, polyamide, and polysulfone. In one aspect, the lens 81 is positioned such that the lens does not obstruct the insufflation pathway through the elongate body and out the aperture in the tip. In one aspect, an insufflation channel parallel with the longitudinal axis of the elongate body assists in providing a pathway around the lens extending across the tip cavity and out through the aperture in the tip.


Referring now to FIG. 36, the obturator 10 in one aspect has a transparent disc lens 85 fitted into the tip 7 of the obturator 10. The distal end of the laparoscope 40 is juxtaposed to the disc lens 85. Heat generated by the light from the laparoscope serves to heat the polycarbonate disc lens 85, which in turn heats the lens of the laparoscope 40 to prevent condensation from forming on the lens of the laparoscope 40. The disc lens 85 in one aspect is coated with an anti-fog solution to prevent condensation from forming on the lens 85. The thickness of the lens 85 in one aspect ranges from about 0.001″ to about 0.250″. The lens 85 in one aspect is formed from various transparent materials such as glass, infrared absorbent glass, polycarbonate, acrylic, polyvinyl chloride, PET, PETE, PETG, cellophane, silicone, polyurethane, polyetherimide, polyamide, and polysulfone.


In FIG. 37, in one aspect, the obturator has a transparent disc lens 85 as described above with an elastomeric perimeter seal 88 loosely positioned on the proximal side of the lens. The seal in one aspect is arranged as an o-ring or a planar type seal and serves to create a seal between the distal end of the laparoscope and the proximal face or side of the disc lens 85. The seal 88 prevents body moisture from contacting the lens of the laparoscope 40 and therefore prevents condensation from collecting on the laparoscope lens. The disc lens 85 in one aspect is coated with an anti-fog solution to prevent condensation from collecting on the surfaces of the disc lens 85. The elastomeric perimeter seal 88 in one aspect is formed from various materials such as polyisoprene, silicone, urethane, ethylene propylene diene monomer, Kraton®, nitrile, neoprene, or various closed cell foam materials. The elastomeric perimeter seal 88 in one aspect is adhered to the disc lens 85 through an over-molding process. The elastomeric perimeter seal 88 in one aspect is bonded to the disc lens 85 with an adhesive.


Accordingly, the present invention provides a visual insufflation port/obturator. Although this invention has been described in certain specific embodiments, many additional modifications and variations would be apparent to those skilled in the art. It is therefore to be understood that this invention may be practiced otherwise than specifically described, including various changes in the size, shape and materials, without departing from the scope and spirit of the present invention. Thus, embodiments of the present invention should be considered in all respects as illustrative and not restrictive, the scope of the present invention to be determined by the appended claims and their equivalents rather than the foregoing description.

Claims
  • 1. A visual insufflation obturator comprising: an elongate body having a proximal end, a distal end and a body lumen extending from the proximal end of the elongate body to the distal end of the elongate body;a handle connected to the proximal end of the elongate body and having a handle lumen extending from a proximal end of the handle to the proximal end of the elongate body and aligned to the body lumen;a transparent tip connected to the distal end of the elongate body and having a tip cavity aligned to the handle lumen, the tip having a distal enclosed end and an outer surface extending from the distal end of the elongate body to the distal enclosed end with an aperture extending through the outer surface into the tip cavity; anda laparoscope seal, attached to the proximal end of the handle connected to the proximal end of the elongate body, comprising an anti-fog applicator saturated with an anti-fog solution and positioned in a direct pathway that extends through the laparoscope seal and into the elongate body.
  • 2. The obturator of claim 1 wherein the laparoscope seal further comprises a zero seal and an instrument seal axially aligned to and preceding the zero seal.
  • 3. The obturator of claim 2 wherein the anti-fog applicator is a saturated cap forming a proximal end of the laparoscope seal.
  • 4. The obturator of claim 2 further comprising means preventing ingress of tissue into the aperture and into the tip of the obturator.
  • 5. The obturator of claim 1 further comprising a trocar cannula and a trocar housing attached to the trocar cannula, the elongate body and the transparent tip insertable through the trocar housing and the trocar cannula, and the transparent tip extendable out of a distal end of the trocar cannula.
  • 6. The obturator of claim 1 wherein the tip is generally conical with the aperture extending perpendicularly to a longitudinal axis of the elongate body.
  • 7. The obturator of claim 1 wherein the anti-fog applicator is sealed prior to use.
  • 8. The obturator of claim 1 wherein the anti-fog applicator comprises a cylinder saturated with the anti-fog solution.
  • 9. The obturator of claim 1 wherein the anti-fog applicator comprises a foam roller saturated with the anti-fog solution.
  • 10. The obturator of claim 1 wherein the anti-fog solution is a mixture of docusate sodium and distilled water.
  • 11. The obturator of claim 1 further comprising a micro-seal located within the tip cavity.
  • 12. The obturator of claim 1 further comprising a micro-seal located within the aperture between the outer surface of the tip and the tip cavity.
  • 13. The obturator of claim 12 wherein the tip further comprises an integral tissue deflector near the aperture being configured to move body tissue away from the aperture and to prevent the ingress of body tissue into the aperture and into the tip cavity of the obturator.
  • 14. The obturator of claim 12 wherein the tip has a tapered configuration with the outer surface extending distally to a blunt point with a pair of side sections having a common shape and being separated by at least one intermediate section, each side section extends from the blunt point radially outwardly with progressive positions proximally along a longitudinal axis, and a distal portion of each side section is twisted radially with respect to a proximal portion of each side section.
  • 15. The obturator of claim 12 wherein the micro-seal is an elastomeric flat disc valve with slits, in that the slits are closed to prevent ingress of body fluids and moisture, and under pressure from insufflation gas, the slits open enabling the insufflation gas to flow out of the tip cavity, and once pressure from the insufflation gas is removed, the slits close preventing the ingress of body fluids and moisture through the aperture.
  • 16. A visual insufflation obturator comprising: an elongate body having a proximal end, a distal end and a body lumen extending from the proximal end of the elongate body to the distal end of the elongate body;a transparent tip connected to the distal end of the elongate body and having a tip cavity aligned to the body lumen, the tip having a distal enclosed end and an outer surface extending from the distal end of the elongate body to the distal enclosed end with at least one vent hole extending through the outer surface into the tip cavity; anda laparoscope seal, adjacent to the proximal end of the elongate body, comprising a pad saturated with an anti-fog solution and positioned in a direct pathway extending through the laparoscope seal and into the elongate body.
  • 17. The obturator of claim 16 wherein the pad includes at least one slit.
  • 18. The obturator of claim 17 wherein the laparoscope seal further comprises a zero seal and an instrument seal axially aligned to and preceding the zero seal.
  • 19. The obturator of claim 18 further comprising a trocar cannula and a trocar housing attached to the trocar cannula, the elongate body and the transparent tip insertable through the trocar housing and the trocar cannula, and the transparent tip extendable out of a distal end of the trocar cannula.
  • 20. The obturator of claim 19 wherein the anti-fog solution is a mixture of docusate sodium and distilled water.
  • 21. The obturator of claim 19 further comprising a micro-seal located within the tip cavity.
  • 22. The obturator of claim 19 further comprising a micro-seal located within the at least one vent hole between the outer surface of the tip and the tip cavity.
  • 23. The obturator of claim 22 wherein the pad is attached to an outer surface of the laparoscope seal.
  • 24. The obturator of claim 23 wherein the pad is a foam and the at least one slit and an aperture are formed in the foam to define a passageway for a laparoscope through the foam.
  • 25. The obturator of claim 16 wherein the pad is partially formed of foam.
  • 26. A visual insufflation obturator comprising: an elongate shaft having a longitudinal axis, a proximal end, a distal end and a shaft lumen extending from the proximal end of the elongate shaft to the distal end of the elongate shaft along the longitudinal axis;a laparoscope seal positioned at the proximal end of the elongate shaft;a planar pad saturated with an anti-fog solution and having at least one slit, the planar pad positioned over the laparoscope seal;a tip at the distal end of the elongate shaft and having a tip cavity, the tip cavity being interconnected with the shaft lumen; the tip having an inner surface and an outer surface defining a tip wall; the tip including at least one insufflation vent hole extending across the tip wall through the outer surface and the inner surface and into the tip cavity interconnecting the tip cavity with outside of the tip, and the at least one insufflation vent hole having a longitudinal axis that is perpendicular to the longitudinal axis of the elongate shaft;an insufflation gas pathway defined from the proximal end of the elongate shaft and out through the at least one insufflation vent hole for delivery of insufflation gas;an elastomeric flat disc valve with slits, the elastomeric flat disc valve located within the at least one insufflation vent hole between the outer surface of the tip and the tip cavity and arranged in that the slits are closed to prevent ingress of body fluids and moisture, and, under pressure from insufflation gas, the slits open enabling the insufflation gas to flow out of the tip cavity and, once pressure from the insufflation gas is removed, the slits close preventing the ingress of body fluids and moisture through the at least one insufflation vent hole; andan elastomeric tissue deflector adjacent the at least one insufflation vent hole and disposed on the outer surface of the tip, the elastomeric tissue deflector being configured to move body tissue away from the at least one insufflation vent hole and to prevent ingress of body tissue into the at least one insufflation vent hole and into the tip cavity.
  • 27. The obturator of claim 26 further comprising a laparoscope insertable into the shaft lumen of the elongate shaft into the tip cavity, and a cannula having a proximal end and a distal end, the elongate shaft and the tip configured to be movable into and out of the cannula, and the tip configured to extend through the distal end of the cannula during traversal of the tip through tissue.
  • 28. The obturator of claim 27 wherein the tip has a tapered configuration with the outer surface extending distally to a blunt point with a pair of side sections having a common shape and being separated by at least one intermediate section, each side section extends from the blunt point radially outwardly with progressive positions proximally along the longitudinal axis of the elongate shaft, and a distal portion of each side section is twisted radially with respect to a proximal portion of each side section.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/291,390 filed on Oct. 12, 2016 entitled “Visual insufflation port” which is a continuation of U.S. patent application Ser. No. 13/964,735 filed on Aug. 12, 2013, now U.S. Pat. No. 9,492,062, entitled “Visual insufflation port” which is a continuation of U.S. patent application Ser. No. 11/868,883 filed on Oct. 8, 2007 now U.S. Pat. No. 8,517,977 entitled “Visual insufflation port” which claims priority to and benefit of U.S. Provisional Patent Application No. 60/828,529 filed Oct. 6, 2006 entitled “Visual insufflation port” the disclosures of which are all hereby incorporated by reference in their entirety.

US Referenced Citations (338)
Number Name Date Kind
RE682 Peale Apr 1859 E
184573 Becker Nov 1876 A
207932 Alvord Sep 1878 A
224513 Burdon Feb 1880 A
396754 Mayfield Jan 1889 A
764322 Wiegand Jul 1904 A
1147408 Kelis Jul 1915 A
1672258 Hippenmeyer Jun 1928 A
1727495 Wappler Sep 1929 A
1845727 Slaughter Feb 1932 A
2024069 Sharp Dec 1935 A
2102274 Larimore Dec 1937 A
2189343 Fritz Feb 1940 A
2301338 Smith Nov 1942 A
2434594 Schultz Jan 1948 A
2441143 Gracey May 1948 A
2646701 Lietin Jul 1953 A
2699770 Fourestier et al. Jan 1955 A
2764148 Sheldon Sep 1956 A
2764149 Sheldon Sep 1956 A
2769355 Henry Nov 1956 A
2877368 Sheldon Mar 1959 A
2932294 Fourestier et al. Apr 1960 A
3005468 Erwin et al. Oct 1961 A
3021834 Sheldon Feb 1962 A
3033226 Allen May 1962 A
3042022 Sheldon Jul 1962 A
3224320 Knudsen Dec 1965 A
3277922 Eisel Oct 1966 A
3279460 Sheldon Oct 1966 A
3357433 Fourestier et al. Dec 1967 A
3385553 Braun May 1968 A
3417745 Sheldon Dec 1968 A
3437747 Sheldon Apr 1969 A
3459189 Alley et al. Aug 1969 A
3556085 Takahashi Jan 1971 A
3613684 Sheridan Oct 1971 A
3653338 Sauey Apr 1972 A
3791379 Storz Feb 1974 A
3817251 Hasson Jun 1974 A
3821956 Gordhamer Jul 1974 A
3870036 Fiore Mar 1975 A
3961621 Northeved Jun 1976 A
3971385 Corbett Jul 1976 A
3994287 Turp Nov 1976 A
3994301 Agris Nov 1976 A
4028987 Wilson Jun 1977 A
4112932 Chiulli Sep 1978 A
4126291 Gilbert et al. Nov 1978 A
4150929 Brandt Apr 1979 A
4168882 Hopkins Sep 1979 A
4180068 Jacobsen et al. Dec 1979 A
4191191 Auburn Mar 1980 A
4222375 Martinez Sep 1980 A
4248214 Hannah et al. Feb 1981 A
4254762 Yoon Mar 1981 A
4269192 Matsuo May 1981 A
4274771 Nishimura Jun 1981 A
4285618 Shanley Aug 1981 A
4299230 Kubota Nov 1981 A
4311138 Sugarman Jan 1982 A
4319563 Kubota Mar 1982 A
4356826 Kubota Nov 1982 A
4386179 Sterling May 1983 A
4414966 Stednitz Nov 1983 A
4429856 Jackson Feb 1984 A
4436519 O'Neill Mar 1984 A
4493444 Deli et al. Jan 1985 A
4498902 Ash et al. Feb 1985 A
4524805 Hoffman Jun 1985 A
4535773 Yoon Aug 1985 A
4535808 Hoffman Aug 1985 A
4537593 Alchas Aug 1985 A
4567882 Heller Feb 1986 A
4601710 Moll Jul 1986 A
4607619 Seike et al. Aug 1986 A
4750877 McFarlane Jun 1988 A
4762130 Fogarty et al. Aug 1988 A
4779613 Hashiguchi et al. Oct 1988 A
4803999 Liegner Feb 1989 A
4813400 Washizuka et al. Mar 1989 A
4850393 Lashomb Jul 1989 A
4869717 Adair Sep 1989 A
4895431 Tsujluchi et al. Jan 1990 A
4901142 Ikuno et al. Feb 1990 A
4956143 McFarlane Sep 1990 A
4959067 Muller Sep 1990 A
4972827 Kishi et al. Nov 1990 A
4978350 Wagenknecht Dec 1990 A
5017057 Kruygor May 1991 A
5030210 Alchas Jul 1991 A
5041100 Rowland et al. Aug 1991 A
5057082 Burchette, Jr. Oct 1991 A
5066288 Deniego et al. Nov 1991 A
5098379 Conway Mar 1992 A
5098388 Kulkashi et al. Mar 1992 A
5104316 McSpadden Apr 1992 A
5104388 Quackenbush Apr 1992 A
5104389 Deem et al. Apr 1992 A
5114407 Burbank May 1992 A
5116547 Tsukahara et al. May 1992 A
5144942 Decarie et al. Sep 1992 A
5147376 Pianetti Sep 1992 A
5159920 Condon et al. Nov 1992 A
5163941 Garth et al. Nov 1992 A
5178186 Levasseur Jan 1993 A
5186972 Williams et al. Feb 1993 A
5197955 Stephens et al. Mar 1993 A
5207656 Kranys May 1993 A
5217441 Shichman Jun 1993 A
5221163 Nishimura Jun 1993 A
5240397 Fay et al. Aug 1993 A
5246425 Hunsberger et al. Sep 1993 A
5250068 Ideguchi et al. Oct 1993 A
5256149 Banik et al. Oct 1993 A
5258003 Ciaglia Nov 1993 A
5269316 Spitainy Dec 1993 A
5271380 Riek et al. Dec 1993 A
5279567 Ciaglia et al. Jan 1994 A
5288290 Brody Feb 1994 A
5290276 Sewell Mar 1994 A
5290585 Elton Mar 1994 A
5300033 Miller May 1994 A
5334150 Kaali Aug 1994 A
5342382 Brinkerhoff Aug 1994 A
5350364 Stephens et al. Sep 1994 A
5366446 Tal et al. Nov 1994 A
5370624 Edwards et al. Dec 1994 A
5372588 Farley Dec 1994 A
5374253 Burns, Sr. et al. Dec 1994 A
5380291 Kaali Jan 1995 A
5387197 Smith Feb 1995 A
5389077 Melinyshin et al. Feb 1995 A
5391153 Haber et al. Feb 1995 A
5391248 Brain Feb 1995 A
5392766 Masterson et al. Feb 1995 A
5405328 Vidal et al. Apr 1995 A
5407427 Zhu et al. Apr 1995 A
5431151 Riek et al. Jul 1995 A
5441041 Sauer et al. Aug 1995 A
5443484 Kirsch et al. Aug 1995 A
5445615 Yoon et al. Aug 1995 A
5454791 Tovey et al. Oct 1995 A
5480410 Cuschieri et al. Jan 1996 A
5510065 McFarlane Apr 1996 A
5540711 Kieturakis et al. Jul 1996 A
5542845 Jenkins Aug 1996 A
5549546 Schneider et al. Aug 1996 A
5551947 Kaai Sep 1996 A
5562696 Nobles et al. Oct 1996 A
5569291 Privitera Oct 1996 A
5569292 Scwemberger et al. Oct 1996 A
5577993 Zhu et al. Nov 1996 A
5591186 Wurster et al. Jan 1997 A
5591192 Privitera et al. Jan 1997 A
5593402 Patrick Jan 1997 A
5603720 Kieturakis Feb 1997 A
5609562 Kaali Mar 1997 A
5609604 Schwemberger et al. Mar 1997 A
5613954 Nelson et al. Mar 1997 A
5622462 Gakhar et al. Apr 1997 A
5630805 Ternamian May 1997 A
5634908 Loomas Jun 1997 A
5658236 Sauer Aug 1997 A
5662615 Blake, III Sep 1997 A
5662673 Kieturakis Sep 1997 A
5676611 Foster Oct 1997 A
5685820 Riek et al. Nov 1997 A
5695462 Sutcu et al. Dec 1997 A
5697947 Wolf Dec 1997 A
5720730 Blake, III Feb 1998 A
5720761 Kaali Feb 1998 A
5735867 Golser et al. Apr 1998 A
5738628 Sierocuk Apr 1998 A
5743881 Demco Apr 1998 A
5746734 Domandy, Jr. et al. May 1998 A
5752970 Yoon et al. May 1998 A
5759185 Grinberg Jun 1998 A
5779697 Glowa et al. Jul 1998 A
5785693 Halninig Jul 1998 A
5792112 Hart et al. Aug 1998 A
5797888 Yoon et al. Aug 1998 A
5797944 Nobeles et al. Aug 1998 A
5817061 Goodwin et al. Oct 1998 A
5817062 Flom et al. Oct 1998 A
5836957 Shulz Nov 1998 A
5842971 Yoon Dec 1998 A
5860996 Urban et al. Jan 1999 A
5865809 Moenning et al. Feb 1999 A
5871474 Hermann et al. Feb 1999 A
5876202 Berlin Mar 1999 A
5882340 Yoon Mar 1999 A
5884639 Chen Mar 1999 A
5891013 Thompson Apr 1999 A
5893865 Swindle Apr 1999 A
5904699 Schwemberger et al. May 1999 A
5913818 Co et al. Jun 1999 A
5922351 Daher Jul 1999 A
5924452 Szpapa et al. Jul 1999 A
5941852 Dunlap et al. Aug 1999 A
5957884 Hooven Sep 1999 A
5957888 Hinchliffe Sep 1999 A
5968060 Kellogg Oct 1999 A
5976079 Volz et al. Nov 1999 A
5976168 Chin Nov 1999 A
5980809 Crain et al. Nov 1999 A
5984941 Wilson Nov 1999 A
6001084 Riek Dec 1999 A
6007481 Riek et al. Dec 1999 A
6007544 Kim Dec 1999 A
6019776 Preissman Feb 2000 A
6024551 Yamaguchi Feb 2000 A
6030406 Davis Feb 2000 A
6043310 Liu et al. Mar 2000 A
6053194 Nelson et al. Apr 2000 A
6068637 Popov et al. May 2000 A
6077481 Ichida et al. Jun 2000 A
6092551 Bennett Jul 2000 A
6168355 Wardell Jan 2001 B1
6179528 Wardell Jan 2001 B1
6203559 Davis Mar 2001 B1
6203745 Wachsmann et al. Mar 2001 B1
6221061 Engelson et al. Apr 2001 B1
6228059 Astarita May 2001 B1
6228063 Aboul-Hosn May 2001 B1
6270484 Yoon Aug 2001 B1
6302873 Moenning Oct 2001 B1
6319266 Stellon Nov 2001 B1
6346074 Roth Feb 2002 B1
6355014 Zadno-Azizi et al. Mar 2002 B1
6387043 Yoon May 2002 B1
6462111 Singh et al. Oct 2002 B1
6468228 Topel et al. Oct 2002 B1
6478806 McFarlane Nov 2002 B2
6508759 Taylor et al. Jan 2003 B1
6520939 Lafontaine Feb 2003 B2
6579298 Bruneau et al. Jul 2003 B1
6656160 Taylor et al. Dec 2003 B1
6656198 Tsonton et al. Dec 2003 B2
6685630 Sauer et al. Feb 2004 B2
6764107 Obahi et al. Jul 2004 B1
6770731 Mason et al. Aug 2004 B2
6835201 O'Heeron Dec 2004 B2
6884253 McFarlane Apr 2005 B1
6887194 Hart et al. May 2005 B2
6902541 McNally et al. Jun 2005 B2
6939296 Ewers et al. Sep 2005 B2
7008979 Schottman et al. Mar 2006 B2
7037303 Beaufore et al. May 2006 B2
7056294 Khairkhahan et al. Jun 2006 B2
7056329 Kerr Jun 2006 B2
7070586 Hart et al. Jul 2006 B2
7182752 Stubbs Feb 2007 B2
7344519 Wing et al. Mar 2008 B2
7370709 Williamson, Jr. May 2008 B2
7470255 Sterns et al. Dec 2008 B2
7563250 Wenchell Jul 2009 B2
7686823 Pingleton et al. Mar 2010 B2
7708713 Albrecht et al. May 2010 B2
7758603 Taylor et al. Jul 2010 B2
7794644 Taylor et al. Sep 2010 B2
7811253 Hart et al. Oct 2010 B2
7942862 Hart et al. May 2011 B2
7947058 Kahle et al. May 2011 B2
8007477 Johnson et al. Aug 2011 B2
8028395 Taylor et al. Oct 2011 B2
8075530 Taylor et al. Dec 2011 B2
8105285 Hart et al. Jan 2012 B2
8128590 Albrecht et al. Mar 2012 B2
8152828 Taylor et al. Apr 2012 B2
8267952 Kahle et al. Sep 2012 B2
8282663 Smith Oct 2012 B2
8292853 Hart et al. Oct 2012 B2
8317815 Mastri et al. Nov 2012 B2
8377090 Taylor et al. Feb 2013 B2
8382663 Taylor Feb 2013 B2
8608769 Kahle et al. Dec 2013 B2
8961493 Hart et al. Feb 2015 B2
9155558 Albrecht et al. Oct 2015 B2
20020013597 McFarlane Jan 2002 A1
20020026207 Stellon et al. Feb 2002 A1
20020133188 O'Heeron et al. Sep 2002 A1
20020183715 Mantell et al. Dec 2002 A1
20020183775 Tsonton et al. Dec 2002 A1
20030023201 Aboul-Hosn Jan 2003 A1
20030032755 Gomey et al. Feb 2003 A1
20030059263 Chen Mar 2003 A1
20030187471 Cooper Oct 2003 A1
20040015185 Ewers et al. Jan 2004 A1
20040082969 Kerr Apr 2004 A1
20040093000 Kerr May 2004 A1
20040093018 Johnson et al. May 2004 A1
20040106942 Taylor et al. Jun 2004 A1
20040108623 Deeter et al. Jun 2004 A1
20040167559 Taylor et al. Aug 2004 A1
20040199127 Jensen et al. Oct 2004 A1
20040204671 Stubbs et al. Oct 2004 A1
20040230155 Blanco et al. Nov 2004 A1
20040230217 O'Heeroon Nov 2004 A1
20040254517 Quiroz-Mercado et al. Dec 2004 A1
20050033237 Fentress Feb 2005 A1
20050033246 Ahlberg et al. Feb 2005 A1
20050038466 O'Heeron et al. Feb 2005 A1
20050059865 Kahle Mar 2005 A1
20050065543 Kahle et al. Mar 2005 A1
20050107803 Guanche May 2005 A1
20050107816 Pingleton et al. May 2005 A1
20050113533 Shaikh et al. May 2005 A1
20050149094 Kashara et al. Jul 2005 A1
20050149096 Hilal et al. Jul 2005 A1
20050159711 Kathrani et al. Jul 2005 A1
20050216028 Hart et al. Sep 2005 A1
20050227610 Zukor et al. Oct 2005 A1
20050273133 Schluzas et al. Dec 2005 A1
20050283122 Nordgren Dec 2005 A1
20050288622 Albrecht et al. Dec 2005 A1
20060030755 Ewers et al. Feb 2006 A1
20060041270 Lenker et al. Feb 2006 A1
20060030870 Staudner Mar 2006 A1
20060047284 Gresham Mar 2006 A1
20060058570 Rapach et al. Mar 2006 A1
20060074374 Gresham Apr 2006 A1
20060118189 Trekulve et al. Jun 2006 A1
20060224174 Smith et al. Oct 2006 A1
20060264991 Johnson Nov 2006 A1
20070027453 Hart et al. Feb 2007 A1
20070075465 Taylor et al. Apr 2007 A1
20070088277 McGinley Apr 2007 A1
20070239108 Albrecht et al. Oct 2007 A1
20080065021 Jenkins et al. Mar 2008 A1
20080086074 Taylor et al. Apr 2008 A1
20080086093 Steppe et al. Apr 2008 A1
20090030375 Franer et al. Jan 2009 A1
20090137943 Steams et al. May 2009 A1
20090187079 Albrecht et al. Jul 2009 A1
20090281500 Acosta et al. Nov 2009 A1
20100025045 Lake et al. Feb 2010 A1
20140114339 Pingleton et al. Apr 2014 A1
Foreign Referenced Citations (67)
Number Date Country
1 006 811 Dec 1994 BE
2 170 841 Sep 1997 CA
0365049 Dec 1922 DE
1616107 Apr 1971 DE
2218901 Oct 1973 DE
2538758 Mar 1977 DE
2929233 Jan 1980 DE
2922239 Dec 1980 DE
4020956 Jan 1991 DE
4133073 Apr 1992 DE
4035146 May 1992 DE
4116648 Nov 1992 DE
29503750 Apr 1995 DE
29521431 Apr 1997 DE
19541041 May 1997 DE
19718086 Nov 1998 DE
19819432 Nov 1999 DE
0135364 Mar 1985 EP
0135364 Mar 1986 EP
0312787 Apr 1989 EP
0347140 Dec 1989 EP
0369936 May 1990 EP
0369937 May 1990 EP
0474124 Mar 1992 EP
0548612 Jun 1993 EP
0556056 Aug 1993 EP
0664992 Aug 1995 EP
0724864 Aug 1996 EP
1074224 Feb 2001 EP
1582158 Oct 2005 EP
2229897 Sep 2010 EP
2233090 Sep 2010 EP
1370580 Aug 1964 FR
2 124 970 Feb 1984 GB
186 005 Sep 1992 GB
2 313 316 Nov 1997 GB
408127661 May 1996 JP
09-173342 Jul 1997 JP
2001-137253 May 2001 JP
0942730 Jul 1982 SU
1328658 Aug 1987 SU
1329769 Aug 1987 SU
WO 199325148 Dec 1993 WO
WO 199833536 Feb 1994 WO
WO 199411040 May 1994 WO
WO 9601074 Jan 1996 WO
WO 199601132 Jan 1996 WO
WO 199610361 Apr 1996 WO
WO 199740758 Nov 1997 WO
WO 199902089 Jan 1999 WO
WO 199915084 Apr 1999 WO
WO 2000018306 Apr 2000 WO
WO 2000054648 Sep 2000 WO
WO 200101847 Jan 2001 WO
WO 200101871 Jan 2001 WO
WO 2001008563 Feb 2001 WO
WO 2002001998 Jan 2002 WO
WO 2001008563 Feb 2002 WO
WO 2002034108 May 2002 WO
WO 2002041795 May 2002 WO
WO 2003026512 Apr 2003 WO
WO 2003032819 Apr 2003 WO
WO 2003096879 Nov 2003 WO
WO 2004037097 May 2004 WO
WO 2004093699 Nov 2004 WO
WO 2005063134 Jul 2005 WO
WO 2007093957 Aug 2007 WO
Non-Patent Literature Citations (70)
Entry
U.S. Appl. No. 10/745,262, filed Dec. 23, 2003; Title: “Catheter With Conduit Traversing Tip” (abandoned).
Co-Pending U.S. Appl. No. 12/750,372, filed Mar. 30, 2010, title: “Bladeless Obturator”.
Co-Pending U.S. Appl. No. 11/549,872, filed Oct. 16, 2006, title: “Surgical Devices, Systems and Methods Thereof Having Gel Material, Gel Coatings, or Gel Lubricants”.
Co-Pending U.S. Appl. No. 13/565,972, filed Aug. 3, 2012, title: “Bladeless Optical Obturator”.
Co-Pending U.S. Appl. No. 13/356,260, filed Jan. 23, 2012, title: “Insufflating Optical Surgical Instrument”.
Co-Pending U.S. Appl. No. 13/078,750, filed Apr. 1, 2011 title “Surgical Access Apparatus and Method”.
Co-Pending U.S. Appl. No. 12/569,652, filed Sep. 29, 2009; title “First-Entry Trocar System”.
Co-Pending U.S. Appl. No. 12/359,964, filed Jan. 26, 2009, title: “Insufflating Access System”.
Co-Pending U.S. Appl. No. 13/462,330, filed May 2, 2012, title: “Low-Profile Surgical Universal Access Port”.
Co-Pending U.S. Appl. No. 13/411,244, filed Mar. 2, 2012, title: “Blunt Tip Obturator”.
Co-Pending U.S. Appl. No. 13/586,825, filed Aug. 15, 2012, title: “Blunt Tip Obturator”.
Co-Pending U.S. Appl. No. 11/868,883, filed Oct. 8, 2007; Title: “Visual Insufflation Port”.
International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US04/032346, dated May 20, 2008.
International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2005/022716 dated Nov. 22, 2005.
International Bureau of WIPO, International Preliminary Report on Patentability for International Application No. PCT/US2006/060013, dated Apr. 24, 2008.
International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2009/058792, titled First Entry Trocar System, dated Mar. 29, 2011.
International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2007/080724, titled “Visual Insufflation Port”, dated Apr. 7, 2009.
International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2009/32026, titled “Insufflating Access System”, dated Jul. 27, 2010.
International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2004/000695, titled “Surgical Access Apparatus and Method”, dated Jul. 22, 2005.
International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2004/04883, titled “Surgical Access Apparatus and Method”, dated Sep. 9, 2005.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US2004/000695, titled “Surgical Access Apparatus and Method”, dated Jan. 12, 2005.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US2004/04883, titled “Surgical Access Apparatus and Method”, dated Mar. 31, 2005.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US2002/06759, titled “Bladeless Obturator”, dated Jul. 12, 2002.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US2005/022716, titled “Insufflating Optical Surgical Instrument”, dated Nov. 22, 2005.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US04/32346, titled Bladeless Optical Obturator, dated May 20, 2008.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US2009/32026, titled “Insufflating Access System”, dated Mar. 23, 2009.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US2007/080724, titled “Visual Insufflation Port”, dated Apr. 16, 2008.
International Searching Authority/US, International Search Report and the Written Opinion of the International Searching Authority dated May 27, 2009, for International Application No. PCT/US2009/037863, titled “Instrument Seal with Inverting Shroud”, dated May 27, 2009.
The International Searching Authority, The International Search Report and the Written Opinion for International Application No. PCT/US2009/058792, titled “First Entry Trocar System”, dated Dec. 23, 2009.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US2012/036119, title “Low-Profile Surgical Universal Access Port”, dated Nov. 7, 2012.
European Patent Office, Supplementary European Search Report for European Patent Application No. EP 04 70 1731 based on International Application No. PCT/US2004/000695, titled “Surgical Access Apparatus and Method”, dated Apr. 11, 2007.
European Patent Office, Supplementary European Search Report for European Patent Application No. EP 02706494.8, titled “Bladeless Obturator”, dated Jun. 24, 2008.
European Patent Office, Supplementary European Search Report for European Patent Application No. EP 03753017.7, titled “Blunt Tip Obturator”, dated Nov. 21, 2008.
European Patent Office, Supplementary European Search Report for European Patent Application No. EP 04712378, titled “Surgical Access Apparatus and Method”, dated May 19, 2008.
European Patent Office, Supplementary European Search Report for European Patent Application No. EP 07843973.4, titled “Visual Insufflation Port” dated Oct. 4, 2008.
European Patent Office, Supplementary European Search Report for European Patent Application No. EP 04793965.7, titled “Bladeless Optical Obturator”, dated Apr. 16, 2010.
European Patent Office, Supplementary European Search Report for European Patent Application No. EP 11154547.1, titled “Blunt Tip Obturator”, dated Mar. 22, 2011.
European Patent Office, European Search Report for European Application No. 11191191.3, titled “Bladeless Obturator” dated Feb. 29, 2012.
European Patent Office, European Search Report for European Application No. 11191179.8, titled “Bladeless Obturator”, dated Feb. 21, 2012.
European Patent Office, European Search Report for European Application No. 11191193.9, titled “Bladeless Obturator”, dated Mar. 5, 2012.
European Patent Office, European Search Report for European Application No. 11191187.1, titled Bladeless Obturator, dated Feb. 23, 2012.
European Patent Office, European Search Report for European Application No. 11191184.8, titled “Bladeless Obturator”, dated Feb. 23, 2012.
European Patent Office, European Search Report for European Application No. 11191189.7, titled “Bladeless Obturator”, dated Feb. 24, 2012.
European Patent Office, European Search Report for European Application No. 11191175.6, titled “Bladeless Obturator”, dated Feb. 21, 2012.
European Patent Office, European Search Report for European Application No. 047017314, titled “Surgical Access Apparatus and Method”, dated Mar. 30, 2007.
Taut, Inc., ADAPT—Asymmetrical Dilating Access Port, Geneva Illinois.
Karl Storz, The Karl Storz Ternamian EndoTIP (TM) System, date: Aug. 27, 2001.
Karl Storz, Zerocart Trocar with eccentric tip, Recklinghausen, Germany, date Mar. 7, 2001.
Ethicon Endo-Surgery, Inc., Endopath Minimally Invasive Access, date: 2001.
European Patent Office, Invitation to Pay Additional Fees for International Application No. PCT/US2012/036119, titled “Low-Profile Surgical Universal Access Port”, dated Jul. 13, 2012.
European Patent Office, European Search Report for European Application No. 12187933, titled “Insufflating Optical Surgical Instrument”, dated Nov. 20, 2012.
European Patent Office, European Search Report for European Application No. 12187929, titled “Insufflating Optical Surgical Instrument”, dated Nov. 20, 2012.
European Patent Office, European Search Report for European Application No. 12186716.2, titled “Bladeless Optical Obturator”, dated Mar. 7, 2013.
European Patent Office, European Search Report for European Application No. 12186717.0, titled “Bladeless Optical Obturator”, dated Mar. 7, 2013.
European Patent Office, European Search Report for European Application No. 12186712.1, titled “Bladeless Optical Obturator”, dated Mar. 7, 2013.
European Patent Office, European Search Report for European Application No. 12186720.4, titled “Bladeless Optical Obturator”, dated Mar. 7, 2013.
International Searching Authority, International Search Report and Written Opinion for International Application No. PCT/US2013/023458 titled “Adaptable Obturator for Various Sized Trocars”, dated Mar. 19, 2013.
European Patent Office, European Search Report for European Application No. 12186722.0, titled “Bladeless Optical Obturator”, dated Mar. 20, 2013.
European Patent Office, European Search Report for European Application No. 12186721.2, titled “Bladeless Optical Obturator”, dated Mar. 22, 2013.
European Patent Office, European Search Report for European Application No. 12186723.8, titled “Bladeless Optical Obturator”, dated Mar. 22, 2013.
European Patent Office, European Search Report for European Patent No. 15185511, dated Jan. 14, 2016.
International Bureau of WIPO, The International Preliminary Report on Patentability for International Application No. PCT/US2005/0022716 titled “Insufflating Optical Surgical Instrument”, dated Jan. 18, 2007, 11 pgs.
European Patent Office, European Search Report for European Patent No. 15184957, titled “Insufflating Optical Surgical Instrument,” dated Dec. 1, 2015, 5 pgs.
European Patent Office, European Search Report for European Patent No. 18155145.8, titled “First Entry Trocar System,” dated Apr. 9, 2018, 6 pgs.
Yang, Guoqing, Hong Jun, Zhu, Linbo, Li Baotong, Xiong Meihua, and Wang Fei, Chinese Journal of Mechanical Engineering, (vol. 26, No. 3, 2013), Three-Dimensional Finite Element Analysis of the Mechanical Properties of Helical Threat Connection, Received Jun. 7, 2012, Revised Jan. 28, 2013, Accepted Feb. 27, 2013.
European Patent Office, European Communication pursuant to Article 94(3) EPC for European Patent Application No. 12186717 .0, titled “Bladeless Optical Obturator”, dated Mar. 26, 2013, 6 pgs.
European Patent Office, European Search Report for European Application No. 15163037.3, titled “Bladeless Optical Obturator” dated Jul. 30, 2015, 7 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 18186509.8, titled “Insufflating Optical Surgical Instrument,” dated Jan. 4, 2019, 7 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 19175227.8, titled “First Entry Trocar System,” dated Jul. 30, 2019, 7 pgs.
European Patent Office, Extended European Search Report for European Patent Application No. EP 19189275.1, titled “Visual Insufflation Port,” dated Oct. 29, 2019, 8 pgs.
Related Publications (1)
Number Date Country
20190105078 A1 Apr 2019 US
Provisional Applications (1)
Number Date Country
60828529 Oct 2006 US
Continuations (3)
Number Date Country
Parent 15291390 Oct 2016 US
Child 16198512 US
Parent 13964735 Aug 2013 US
Child 15291390 US
Parent 11868883 Oct 2007 US
Child 13964735 US